guaifenesin has been researched along with Diabetes Mellitus, Type 1 in 7 studies
Guaifenesin: An expectorant that also has some muscle relaxing action. It is used in many cough preparations.
Diabetes Mellitus, Type 1: A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In preclinical models of Type 1 Diabetes (T1D) the integrity of the gut barrier (GB) is instrumental to avoid dysregulated crosstalk between the commensal microbiota and immune cells and to prevent autoimmunity." | 1.91 | Alterations of the intestinal mucus layer correlate with dysbiosis and immune dysregulation in human Type 1 Diabetes. ( Antonini Cencicchio, M; Bolla, AM; Bosi, E; Cosorich, I; Devecchi, E; Diana, J; Falcone, M; Fasano, A; Ferrarese, R; Lamparelli, LA; Liang, W; Lo Conte, M; Mancini, N; Massimino, L; Nobili, A; Palmieri, V; Pedone, E; Riba, M; Scavini, M; Ungaro, F, 2023) |
| "This is the first evidence that autoimmune diabetes-prone NOD mice can also give rise to enhanced Th2-mediated responses and might thus provide a useful model for the study of common genetic and cellular components, including NKT cells that contribute to both asthma and type 1 diabetes." | 1.32 | Exacerbated Th2-mediated airway inflammation and hyperresponsiveness in autoimmune diabetes-prone NOD mice: a critical role for CD1d-dependent NKT cells. ( Araujo, LM; Bach, JF; Diem, S; Dy, M; Herbelin, A; Lefort, J; Leite-de-Moraes, MC; Nahori, MA; Vargaftig, BB; Zhu, R, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 3 (42.86) | 2.80 |
| Authors | Studies |
|---|---|
| Mønsted, MØ | 1 |
| Bilgin, M | 1 |
| Kuzma, M | 1 |
| Pelantová, H | 1 |
| Pedersen, K | 1 |
| Tomášová, P | 1 |
| Nazmutdinova, A | 1 |
| Šedivá, B | 1 |
| Funda, D | 1 |
| Castro-Mejía, JL | 1 |
| Holm, LJ | 1 |
| Nielsen, DS | 1 |
| Haupt-Jorgensen, M | 1 |
| Lo Conte, M | 1 |
| Cosorich, I | 1 |
| Ferrarese, R | 1 |
| Antonini Cencicchio, M | 1 |
| Nobili, A | 1 |
| Palmieri, V | 1 |
| Massimino, L | 1 |
| Lamparelli, LA | 1 |
| Liang, W | 1 |
| Riba, M | 1 |
| Devecchi, E | 1 |
| Bolla, AM | 1 |
| Pedone, E | 1 |
| Scavini, M | 1 |
| Bosi, E | 1 |
| Fasano, A | 1 |
| Ungaro, F | 1 |
| Diana, J | 1 |
| Mancini, N | 1 |
| Falcone, M | 1 |
| Sintsova, O | 1 |
| Popkova, D | 1 |
| Kalinovskii, A | 1 |
| Rasin, A | 1 |
| Borozdina, N | 1 |
| Shaykhutdinova, E | 1 |
| Klimovich, A | 1 |
| Menshov, A | 1 |
| Kim, N | 1 |
| Anastyuk, S | 1 |
| Kusaykin, M | 1 |
| Dyachenko, I | 1 |
| Gladkikh, I | 1 |
| Leychenko, E | 1 |
| Miranda, MCG | 1 |
| Oliveira, RP | 1 |
| Torres, L | 1 |
| Aguiar, SLF | 1 |
| Pinheiro-Rosa, N | 1 |
| Lemos, L | 1 |
| Guimarães, MA | 1 |
| Reis, D | 1 |
| Silveira, T | 1 |
| Ferreira, Ê | 1 |
| Moreira, TG | 1 |
| Cara, DC | 1 |
| Maioli, TU | 1 |
| Kelsall, BL | 1 |
| Carlos, D | 1 |
| Faria, AMC | 1 |
| Araujo, LM | 1 |
| Lefort, J | 1 |
| Nahori, MA | 1 |
| Diem, S | 1 |
| Zhu, R | 1 |
| Dy, M | 1 |
| Leite-de-Moraes, MC | 1 |
| Bach, JF | 1 |
| Vargaftig, BB | 1 |
| Herbelin, A | 1 |
| Yue, WL | 1 |
| Brandstetter, RD | 1 |
| Tamarin, FM | 1 |
| Washington, D | 1 |
| Wing, M | 1 |
| Eufemio, M | 1 |
7 other studies available for guaifenesin and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Reduced phosphatidylcholine level in the intestinal mucus layer of prediabetic NOD mice.
Topics: Animals; Diabetes Mellitus, Type 1; Mice; Mice, Inbred C57BL; Mice, Inbred NOD; Mucus; Phosphatidylc | 2023 |
Alterations of the intestinal mucus layer correlate with dysbiosis and immune dysregulation in human Type 1 Diabetes.
Topics: Diabetes Mellitus, Type 1; Dysbiosis; Humans; Intestinal Mucosa; Mucins; Mucus; RNA, Messenger; RNA, | 2023 |
Control of postprandial hyperglycemia by oral administration of the sea anemone mucus-derived α-amylase inhibitor (magnificamide).
Topics: Administration, Oral; alpha-Amylases; alpha-Glucosidases; Animals; Blood Glucose; Diabetes Mellitus, | 2023 |
Frontline Science: Abnormalities in the gut mucosa of non-obese diabetic mice precede the onset of type 1 diabetes.
Topics: Animals; Cytokines; Dendritic Cells; Diabetes Mellitus, Type 1; Disease Progression; Dysbiosis; Fema | 2019 |
Exacerbated Th2-mediated airway inflammation and hyperresponsiveness in autoimmune diabetes-prone NOD mice: a critical role for CD1d-dependent NKT cells.
Topics: Animals; Antibodies, Monoclonal; Antigens, CD1; Antigens, CD1d; Asthma; Bronchial Hyperreactivity; B | 2004 |
Nasal mucociliary clearance in patients with diabetes mellitus.
Topics: Adolescent; Adult; Aged; Diabetes Mellitus, Type 1; Female; Humans; Hydrogen-Ion Concentration; Male | 1989 |
Occult mucous airway obstruction in diabetic ketoacidosis.
Topics: Adult; Blood Gas Analysis; Bronchial Diseases; Carbon Dioxide; Diabetes Mellitus, Type 1; Diabetic K | 1987 |